Fresh leadership has been announced for the CEO Advisory Committee of the International Generic and Biosimilar medicines Association, with Insud Pharma chief executive Lucas Sigman moving up from his previous position of vice-chair to become chair. Allan Oberman, president and CEO of Apotex, has been named as the new vice-chair.
Sigman replaces Lupin CEO Vinita Gupta, who became chair of the committee for 2024. Gupta had herself replaced Richard Saynor, who was the inaugural chair of the advisory...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?